IP Verse

J A Kemp patent opposition analysis

The comprehensive analysis of J A Kemp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by J A Kemp

Stay updated with the latest patent oppositions filed by J A Kemp

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XF HOFFMANN LA ROCHEAug 27, 2025J A KEMP
EP4261346
Production Of Paper- Or LinerboardBILLERUD AKTIEBOLAG PUBLAug 27, 2025STORA ENSO OYJ
EP3305321
Therapeutic Agent And Therapeutic Method For Pulmonary HypertensionKYOWA KIRINJul 16, 2025J A KEMP
EP3487881
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025J A KEMP
EP3950028
Systems And Methods Of Aerosol Delivery With Airflow RegulationALTRIA CLIENT SERVICESMay 7, 2025STRAWMAN
EP3275978
Lubricant Composition For Gasoline Engines And Method For Producing SameIDEMITSU KOSANFeb 7, 2025AFTON CHEMICAL
EP3411476
Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS
EP3888674
Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen ReceptorTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 3, 2025J A KEMP
EP3353544
Differential Output Of Analog Memories Storing Nanopore Measurement SamplesROCHENov 21, 2024OXFORD NANOPORE
EP4121501
Lubricating Oil Compositions For Automatic TransmissionsCHEVRON JAPANOct 23, 2024AFTON CHEMICAL

Top clients of J A Kemp

Top companies who are the clients of J A Kemp

CompanyTotal
J A KEMP39
AFTON CHEMICAL30
REGENERON PHARMACEUTICALS14
LEEMING13
STRAWMAN8
GENMAB7
DSM ASSETS7
WR GRACE & CONN5
GLAXO GROUP4
ALEXION PHARMACEUTICALS3